Fermented ginseng attenuates hepatic lipid accumulation and hyperglycemia through AMPK activation

Food Science and Biotechnology

Volumn 18, Issue 1, 2009, Pages 172-178

  Kim, Do Yeon ^a   Park, Jong Seok ^a   Yuan, Hai Dan ^a   Chung, Sung Hyun ^a  

^a Kyung Hee University   (South Korea)

Author keywords

AMP activated protein kinase; Db db mouse; Fermented ginseng; Hyperglycemia; Hyperlipidemia

Indexed keywords

AMP-ACTIVATED PROTEIN KINASE; DB/DB MOUSE; FERMENTED GINSENG; HYPERGLYCEMIA; HYPERLIPIDEMIA;

ENZYME ACTIVITY; ENZYME INHIBITION; ENZYMES; ETHANOL; GLUCOSE; LIVER; PHOSPHORYLATION;

GENE EXPRESSION;

MUS; PANAX GINSENG;

EID: 77953902626     PISSN: 12267708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. American Diabetes Association. Report of the expert committee onthe diagnosis and classification of diabetes mellitus. Diabetes Care21: S5-S19 (1998)
2. Ferrannini E. Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: Problems and prospects.Endocro. Rev. 19: 477-490 (1998)
3. Gerich JE. The genetic basis of type 2 diabetes mellitus: Impairedinsulin secretion versus impaired insulin sensitivity. Endocro. Rev.19: 491-503 (1998)
4. Weickert MO, Pfeiffer AFH. Signaling mechanisms linking hepaticglucose and lipid metabolism. Diabetologia 49: 1732-1741 (2006)
5. Hardie DG, Carling D. The AMPK-activated protein kinase: Fuelgauge of mammalian cells. Eur. J. Biochem. 246: 259-273 (1998)
6. Hardie DG, Carling D, Scott JW, Pan ER, Hudson ER. The AMP-activated/SNF protein kinase subfamily: Metabolic sensors of theeukaryotic cell? Annu. Rev. Biochem. 67: 821-855 (1998)
7. Hardie DG, Scott JW, Pan DA, Hudson ER. Management of cellularenergy by energy by the AMP-activated protein kinase system.FEBS Lett. 546: 113-120 (2003)
8. Hardie DH, Carling D. The AMP-activated protein kinase. Fuelgauge of the mammalian cell? Eur. J. Biochem. 246: 259-273(1997)
9. Hardie DG, Carling D, Carlson M. The AMP-activated/SNF1protein kinase subfamily: Metabolic sensors of the eukaryotic cell?Annu. Rev. Biochem. 67: 821-855 (1998)
10. Han GC, Ko SK, Sung JH, Chung SH. Compound K enhancesinsulin secretion with beneficial metabolic effects in db/db mice. J.Agr. Food Chem. 55: 10641-10648 (2007)
11. Park MW, Ha JI, Chung SH. 20(S)-Ginsenoside Rg 3 enhances glucose-stimulated insulin secretion and activates AMPK. Biol. Parm. Bull. 31: 748-751 (2008)
12. Vuksan V, Sievenpiper JL. Herbal remedies in the management of diabetes: Lessons learned from the study of ginseng. Nutr. Metab. Cardiovas. 15: 149-160 (2005)
13. Han KL, Jung MH, Sohn JH, Hwang JK. Ginsenoside 20 (S)- protopanaxatriol (PPT) activates peroxisome proliferator-activated receptor γ (PPARγ) in 3T3-L1 adipocytes. Biol. Pharm. Bull. 29: 110-113 (2006)
14. Shang W, Yang Y, Jiang B, Jin H, Zhou L, Liu S, Chen M. Ginsenoside Rb 1promotes adipogenesis in 3T3-L1 cells by enhancing PPARγ2 and C/EBPα gene expression. Life Sci. 80: 618-625 (2007)
15. Lau AJ, WooSO, Koh HL. Analysis of saponins in raw and steamed Ranax notoginseng using high-performance liquid chromatographywith diode array detection. J. Chromatogr. A 1011: 77-87 (2003)
16. Wang YX, Lee CH, Tiep S, Yu RT, Ham J, Kang H, Evans RM. Peroxisome-proliferator-activated receptor δ activates fatmetabolism to prevent obesity. Cell 113: 159-170 (2003)
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turne RL. Homeostasis model assessment insulin resistance and beta-cell function form fasting plasma glucose and insulin concentration in man. Diabetologia 28: 412-419 (1985)
18. Akli S, Chelly J, Lacorte JM, Poenaru L, Kahn A. Seven novel Tay- Sachs mutateions detected by chemical mismatch cleavage of PCR-amplified cDNA fragments. Genomics 11: 124-134 (1991)
19. Viollet B, Foretz M, Guigas B, Horman S, Dentin R, Bertrand L, Hue L, Andreelli F. Activation of AMP-activated protein kinase in the liver: A new strategy for the management of metabolic hepatic disorders. J. Physiol. 574: 41-53 (206)
20. Hardie DG. The AMP-activated protein kinase pathway-new players upstream and downstream. J. Cell Sci. 117: 5479-5487 (2004)
21. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenky-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Gppduer LJ, Moller DE. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108: 1167-1174 (2001)
22. Alarcon-Aguilara FJ, Roman-Ramos R, Perez-Gutierrez S, Aguilar- Contreras A, Contreras-Weber CC, Flores-Saenz JL. Study of the anti-hyperglycemic effect of plants used as antidiabetics. J. Ethnopharmacol. 61: 101-110 (1998)
23. Birnbaum MJ. Activating AMP-activated protein kinase without AMP. Mol. Cell 19: 289-290 (2005)
24. Shaw RJ, Lamia KA, Vasquez D, Koo SH, Bardeesy N, Depinho RA, Montminy M, Cantley LC. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310: 1642-1646 (2005)
25. Moller DE, Kaufman KD. Metabolic syndrome: A clinical and molecular perspective. Annu. Rev. Med. 56: 45-62 (2005)
26. Yamauch T, Kamon J, Waki H, Teruchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Retman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7: 941-953 (2001)